We-Vet

Vet Club_Bayer

immagine

Attività svolta

Desidero ricevere una copia cartacea
Informativa sulla privacy
Iscrizione alla newsletter

Ottava parte

Cardiomiopatie del cane e malattie del pericardio

Bibliografia

1. Arbustini E., Narula N., Dec G.W., et al. The MOGE(S) classification for a phenotype-genotype nomenclature of cardiomyopathy: endorsed by the World Heart Federation. J. Am. Coll. Cardiol. 2013; vol. 62: pp. 2046-2072.

2. Atencia S. Doyle R.S., Whitley N.T. Thoracoscopic pericardial window for management of pericardial effusion in 15 dogs. J. Small Anim. Pract. 2013; vol. 54: pp. 564-569.

3. Beier P., Reese S., Holler P.J., et al. The role of hypothyroidism in the etiology and progression of dilated cardiomyopathy in Doberman Pinschers. J. Vet. Intern. Med. 2015; vol. 29: pp. 141-149.

4. Boddy K.N., Sleeper M.M., Sammarco C.D., et al. Cardiac magnetic resonance in the differentiation of neoplastic and nonneoplastic pericardial effusion. J. Vet. Intern. Med. 2011; vol. 25: pp. 1003-1009.

5. Borgarelli M., Santilla R.A., Chiavegato D., et al. Prognostic indicators for dogs with dilated cardiomyopathy. J. Vet. Intern. Med. 2006; vol. 20: pp. 104-110.

6. Buchanan, J.W. Causes and prevalence of cardiovascular disease. In: Kirk R.W., Bonagura J.D. (Eds.): Kirk’s Current Veterinary Therapy XI. Small Animal Practice. W.B. Saunders, Philadelphia, 1992: pp. 647-655.

7. Cagle L.A., Epstein S.E., Owens S.D., et al. Diagnostic yield of cytologic analysis of pericardial effusion in dogs. J. Vet. Intern. Med. 2014; vol. 28: pp. 66-71.

8. Case J.B., Maxwell M., Aman A., Monnet E.L. Outcome evaluation of a thoracoscopic pericardial window procedure or subtotal pericardectomy via thoracotomy for the treatment of pericardial effusion in dogs. J. Am. Vet. Med. Assoc. 2013; vol. 242: pp. 493-498.

9. Cunningham S.M., Sweeney J.T., MacGregor J., et al. Clinical features of English Bulldogs with presumed arrhythmogenic right ventricular cardiomyopathy: 31 Cases (2001–2013). J. Am. Anim. Hosp. Assoc. 2018; vol. 54: 95-102.

10. Dukes-McEwan J., Borgarelli M., Tidholm A., et al. Proposed guidelines for the diagnosis of canine idiopathic dilated cardiomyopathy. J. Vet. Cardiol. 2003; vol. 5 (2): pp. 7-19.

11. Dunning D., Monnet E., Orton C. et al.: Analysis of prognostic indicators for dogs with pericardial effusion: 46 cases (1985-1996). J. Am. Vet. Med. Assoc. 1998; vol. 212: pp. 1276-1280.

12. Dutton E., Lopez-Alvarez J. An update on canine cardiomyopathies – is it all in the genes? J. Small Anim. Pract. 2018; vol. 59: pp. 455-464.

13. Elliott P., Andersson B., Arbustini E. et al. Classification of the cardiomyopathies: a position statement from the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases. Eur. Heart J. 2008; vol. 29: pp. 270-276.

14. Estrada A.H., Maisenbacher H.W. Dilated cardiomyopathy. In: Bonagura J.D., Twedt D.C. (Eds.): Kirk’s Current Veterinary Therapy XV. Elsevier Saunders, St. Louis, 2014: pp. 795-800.

15. Guglielmini C., Diana A., Santarelli G., et al. Accuracy of the vertebral heart score and sphericity index for detection of pericardial effusion in canine thoracic radiographs. J. Am. Vet. Med. Assoc. 2012; vol. 241: pp. 1048-1055.

16. Guglielmini C., Berlanda M., Fracassi F., et al. Electrocardiographic and echocardiographic evaluation in dogs with hypothyroidism before and after levothyroxine supplementation: A prospective controlled study. J. Vet. Intern. Med. 2019; DOI: 10.1111/jvim.15600. 

17. Humm K.R., Keenaghan-Clark E.A., Boag A.K. Adverse events associated with pericardiocentesis in dogs: 85 cases (1999-2006). J. Vet. Emerg. Crit. Care 2009; vol. 19: pp. 352-356.

18. Klüser L., Holler P.J., Simak J., et al. Predictors of sudden cardiac death in Doberman pinschers with dilated cardiomyopathy. J. Vet. Intern. Med. 2016; vol. 30: pp. 722-732.

19. Lisciandro G.R. The use of the diaphragmatico-hepatic (DH) views of the abdominal and thoracic focused assessment with sonography for triage (AFAST/TFAST) examinations for the detection of pericardial effusion in 24 dogs (2011–2012). ). J. Vet. Emerg. Crit. Care 2016; vol. 26: pp. 125-131.  

20. Maron B.J., Towbin J.A., Thiene G., et al. Contemporary definitions and classification of the cardiomyopathies: an American Heart Association Scientific Statement from the Council on Clinical Cardiology, Heart Failure and Transplantation Committee; Quality of Care and Outcomes Research and Functional Genomics and Translational Biology Interdisciplinary Working Groups; and Council on Epidemiology and Prevention. Circulation 2006; vol. 113: pp. 1807-1816.

21. MacDonald KA. Cagney O. Magne ML. Echocardiographic and clinicopathologic characterization of pericardial effusion in dogs: 107 cases (1985-2006). J Am Vet Med Assoc. 2009; 235:1456-1461.

22. Martin M.W.S., Stafford Johnson M.J., Celona B. Canine dilated cardiomyopathy: a retrospective study of signalment, presentation and clinical findings in 369 cases. J. Small Anim. Pract. 2009; vol. 50: pp. 23-29.

23. Martin M.W.S., Stafford Johnson M.J., Strehlau G., King J.N. Canine dilated cardiomyopathy: a retrospective study of prognostic findings in 367 clinical cases. J. Small Anim. Pract. 2010; vol. 51: pp. 428-436.

24. Mellanby R.J., Herrtage M.E. Long-term survival of 23 dogs with pericardial effusions. Vet. Rec. 2005; vol. 156: pp.568-571.

25. Meurs K.M. Arrhythmogenic right ventricular cardiomyopathy in the boxer dog: an update. Vet. Clin. North. Am. Small Anim. Pract. 2017; vol. 47: pp. 1103-1111.

26. Meurs K.M., Stern J.A., Reina Doreste Y., et al. Natural history of arrhythmogenic right ventricular cardiomyopathy in the boxer dog: a prospective study. J. Vet. Intern. Med. 2014; vol. 28: pp. 1214-1220.

27. Nelson O.L., Ware W.A. Pericardial effusion. In: Bonagura J.D., Twedt D.C. (Eds.): Kirk’s Current Veterinary Therapy XV. Elsevier Saunders, St. Louis, 2014: pp. 816-823.

28. O'Grady M.R., O'Sullivan M.L., Minors S.L., Horne R. Efficacy of benazepril hydrochloride to delay the progression of occult dilated cardiomyopathy in Doberman Pinschers. J. Vet. Intern. Med. 2009; vol. 23: pp. 977-983.

29. Rajagopalan V, Jesty SA, Craig LE, Gompf R. Comparison of presumptive echocardiographic and definitive diagnoses of cardiac tumors in dogs. J. Vet. Intern. Med. 2013; vol. 27: pp. 1092-1096. 

30. Richardson P., McKenna W., Bristow M., et al. Report of the 1995 World Health Organization/International Society and Federation of Cardiology Task Force on the definition and classification of cardiomyopathies. Circulation 1996; vol. 93: pp. 841-842.

31. Scollan K.F., Bottorff B., Stieger-Vanegas S., et al.  Use of multidetector computed tomography in the assessment of dogs with pericardial effusion. J. Vet. Intern. Med. 2015; vol. 29: pp. 79-87. 

32. Sidley J.A., Atkins C.E., Keene B.W., DeFrancesco T.C. Percutaneous balloon pericardiotomy as a treatment for recurrent pericardial effusion in 6 dogs. . J. Vet. Intern. Med. 2002; vol. 16: pp. 541–546.    

33. Stafford Johnson M., Martin M., Binns S., Day M.J. A retrospective study of clinical findings, treatment and outcome in 143 dogs with pericardial effusion. J. Small Anim. Pract. 2004; vol. 45: pp. 546-552.

34. Stepien RL. Whitley NT. Dubielzig RR. Idiopathic or mesothelioma-related pericardial effusion: clinical findings and survival in 17 dogs studied retrospectively. J Small Anim Pract. 2000; 41:342-347.

35. Stern J.A., Meurs K.M. Myocardial disease: canine. In: Ettinger S.J., Feldman E.C., Coté E. (Eds.): Textbook of Veterinary Internal Medicine – Disease of dog and cat. 8th Ed., Elsevier, St. Louis, 2017: pp. 1269-1277

36. Summerfield N.J., Boswood A., O'Grady M.R., et al. Efficacy of pimobendan in the prevention of congestive heart failure or sudden death in Doberman pinscher with preclinical dilated cardiomyopathy (the PROTECT study). J. Vet. Intern. Med. 2012; vol. 26: pp. 1337–1349.

37. Tidholm A., Jönsson L. Histologic characterization of canine dilated cardiomyopathy. Vet. Pathol. 2005; vol. 42: pp 1-8.

38. Vicari E.D., Brown D.C. Holt D.E. et al. : Survival times of and prognostic indicators for dogs with heart base masses: 25 cases (1986-1999). J. Am. Vet. Med. Assoc. 2001; vol. 219: pp. 485-487.

39. Weisse C., Soares N., Beal M,W. et al.: Survival times in dogs with right atrial hemangiosarcoma treated by means of surgical resection with or without adjuvant chemotherapy: 23 cases (1986-2000). J, Am, Vet, Med, Assoc. 2005; vol. 226: pp. 575-579.

40. Wess G., Domenech O., Dukes-McEwan J., et al. European Society of Veterinary Cardiology screening guidelines for dilated cardiomyopathy in Doberman Pinschers. J. Vet. Cardiol. 2017; vol. 19: 405-415.

41. Wright K.N.Connor C.E.Irvin H.M., et al. Atrioventricular accessory pathways in 89 dogs: Clinical features and outcome after radiofrequency catheter ablation. J Vet Intern Med 2018; 32:1517-1529.

TORNA INDIETRO
Abbonati per accedere

Dal web internazionale
14/11/2019

Miocardite associata a coronavirus felino in un gatto a pelo lungo

Un gatto maschio intero a pelo lungo di 9 mesi presentava da tre settimane ipertermia altalenante, calo ponderale e diarrea dell'intestino tenue, che non rispondeva agli antibiotici e al trattamento di supporto.

 
 
ERRATA CORRIGE

Nell’articolo dal titolo “Efficacia e sicurezza di un prodotto spot-on a base di imidacloprid e moxidectina nel trattamento della capillariosi nasale del cane”, pubblicato su Summa 10/2018 a pagina 44, la nota finale “Il presente articolo è stato pubblicato precedentemente su Veterinary Parasitology, 2017, vol. 116, Suppl 1, pp. 65-74”, è da modificarsi in “Il presente articolo è stato pubblicato precedentemente su Parasitology Research, 2017, vol. 116, Suppl 1, pp. 65-74”. Ce ne scusiamo con gli autori e i lettori. 

 

Formazione a distanza abbinata a SUMMA